Explore the latest research on the combination of ropeginterferon alfa-2b with anti-PD1 blockade as adjuvant therapy in HBV-related hepatocellular carcinoma (HCC). This study provides important insights into the potential synergistic effects of immunomodulation and checkpoint inhibition in improving post-operative outcomes. 🔗 Read the full article: https://link.springer.com/article/10.1007/s12072-025-10954-9

Please check out the details of the upcoming STC in Yangon !!APASL STC 2025 YangonTheme: Cirrhosis of the Liver with Special Emphasis on ACLF Consensus.Date: December 13 – 14, 2025ACLF Consensus Meeting,Topic: Therapeutic endpoints in Management of Organ Failure in ACLFPatron: Prof Shiv K SarinOrganizing Chairman- Prof Necati Ormeci and Prof Khin Maung WiOrganizing Secretary: Ashok ChoudhuryEditorial Board- Yun Jun Kim, Ashish Kumar, Anand Kulkarni, Daniel Q. Huang, Reham Soliman,

Explore the latest research on “Plasma exchange improves survival with native liver in Wilson disease with new Wilson’s index ≥ 11 and early hepatic encephalopathy.” This important study highlights the clinical value of plasma exchange in improving outcomes and survival among patients with severe Wilson disease, providing new insights for optimizing management strategies. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10821-7

The following is the main topics for APASL 2026 Istanbul !! https://www.apasl2026istanbul.org/MAIN-TOPICS.html Abstract submission in available until Nov 24, 2025 !! https://www.apasl2026istanbul.org/ABSTRACTS.html We are waiting for your submission !!

Please check out the detailed report from Dr. Soe Thiha Maung, who participated in APASL Early Career Fellowship from July to October,2025. We hope this report will encourage young doctors to apply for ASPASL Fellowship Program 2026, which will offer the winners opportunities to study at their preferred institution with financial support of USD10,000 !! https://www.apasl.info/wp-apasl/wp-content/uploads/2025/11/Final-Report-for-APASL-Fellowship-2025-Dr.-Soe-Thiha-Maung.pdf

Registration has started for APASL Oncology 2026 Tokyo !! We are delighted to announce to you that we have launched the registration for APASL Oncology 2026 Tokyo !! We are looking forward to welcoming a lot of attendees !! https://www.apasl-oncology2026tokyo.org/reg.html

Conference date of APASL STC 2025 Qingdao has been changed to November 28-30, 2025 !! We are waiting for your involvement !!

Please check out our Guideline page from the following URL !! Guidelines

The B-Together study explores the potential of bepirovirsen in modulating immune responses to enhance the clearance of HBV-infected hepatocytes. This research highlights a promising step toward achieving a functional cure for chronic hepatitis B through targeted immunomodulation. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10917-0 #HepatitisB#HBVResearch#Immunotherapy#Hepatology#LiverDisease#Bepirovirsen#HepatologyInternational#ViralHepatitis#ClinicalResearch#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Emerging data from the Paracelsus 10,000 Study reveal a significant association between depression and metabolic dysfunction-associated steatotic liver disease (MASLD), underscoring the complex interplay between mental health and metabolic liver disease. This cross-sectional analysis emphasizes the importance of integrated care approaches in managing patients with MASLD and related comorbidities. Read the full article: https://link.springer.com/article/10.1007/s12072-025-10922-3 #MASLD#LiverHealth#Depression#MentalHealth#Hepatology#MetabolicDisease#HepatologyInternational#LiverResearch#PublicHealth#HealthcareProfessionals

Understanding the stage-specific impact of portal hypertension is crucial in optimizing surgical outcomes for hepatocellular carcinoma (HCC). This study provides valuable insights into how portal hypertension influences prognosis and postoperative outcomes following liver resection, emphasizing the importance of individualized treatment strategies. Read the full article here: https://link.springer.com/article/10.1007/s12072-025-10879-3 #Hepatology#LiverSurgery#HCC#PortalHypertension#LiverResection#HepatologyInternational#LiverCancer#ClinicalResearch#Oncology#Hepatobiliary

Please check out the Scientific Program of APASL STC 2025 Yangon scheduled on December 13-14 !! We are so thrilled to welcome you in the beautiful city of Yangon !! Scientific Program – APASL – SINGLE TOPIC CONFERENCE 2025, YANGON

APASL STC 2025 Pakistan will be held on December 5-7 !! Please check out its details from the following URL !!

APASL STC 2025 Qingdao scheduled on November 1-2 is just around the corner !! We look forward to your active involvement !!